BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18423480)

  • 1. Increased exosome production from tumour cell cultures using the Integra CELLine Culture System.
    Mitchell JP; Court J; Mason MD; Tabi Z; Clayton A
    J Immunol Methods; 2008 Jun; 335(1-2):98-105. PubMed ID: 18423480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2.
    Clayton A; Mitchell JP; Court J; Mason MD; Tabi Z
    Cancer Res; 2007 Aug; 67(15):7458-66. PubMed ID: 17671216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of heat shock proteins in B-cell exosomes.
    Clayton A; Turkes A; Navabi H; Mason MD; Tabi Z
    J Cell Sci; 2005 Aug; 118(Pt 16):3631-8. PubMed ID: 16046478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production.
    Clayton A; Al-Taei S; Webber J; Mason MD; Tabi Z
    J Immunol; 2011 Jul; 187(2):676-83. PubMed ID: 21677139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome from chaperone-rich cell lysates-loaded dendritic cells produced by CELLine 1000 culture system exhibits potent immune activity.
    Bu N; Wu H; Zhang G; Ma X; Zhao P; Zhai N; Xiang L; Cao H; Yang X; Liu J
    Biochem Biophys Res Commun; 2015 Jan; 456(1):513-8. PubMed ID: 25490390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defined protein-free NS0 myeloma cell cultures: stimulation of proliferation by conditioned medium factors.
    Spens E; Häggström L
    Biotechnol Prog; 2005; 21(1):87-95. PubMed ID: 15903244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary human keratinocytes externalize stratifin protein via exosomes.
    Chavez-Muñoz C; Morse J; Kilani R; Ghahary A
    J Cell Biochem; 2008 Aug; 104(6):2165-73. PubMed ID: 18452139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization.
    Laulagnier K; Motta C; Hamdi S; Roy S; Fauvelle F; Pageaux JF; Kobayashi T; Salles JP; Perret B; Bonnerot C; Record M
    Biochem J; 2004 May; 380(Pt 1):161-71. PubMed ID: 14965343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin modulates malignant pleural mesothelioma cell functions in vitro.
    Ohashi R; Tajima K; Takahashi F; Cui R; Gu T; Shimizu K; Nishio K; Fukuoka K; Nakano T; Takahashi K
    Anticancer Res; 2009 Jun; 29(6):2205-14. PubMed ID: 19528482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes for the treatment of human malignancies.
    Viaud S; Ullrich E; Zitvogel L; Chaput N
    Horm Metab Res; 2008 Feb; 40(2):82-8. PubMed ID: 18283625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Difference gel electrophoresis analysis of Ras-transformed fibroblast cell-derived exosomes.
    Ji H; Erfani N; Tauro BJ; Kapp EA; Zhu HJ; Moritz RL; Lim JW; Simpson RJ
    Electrophoresis; 2008 Jun; 29(12):2660-71. PubMed ID: 18494037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomes as novel therapeutic nanodevices.
    Delcayre A; Le Pecq JB
    Curr Opin Mol Ther; 2006 Feb; 8(1):31-8. PubMed ID: 16506523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomes: a bubble ride for prions?
    Février B; Vilette D; Laude H; Raposo G
    Traffic; 2005 Jan; 6(1):10-7. PubMed ID: 15569241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification, characterization and biological significance of tumor-derived exosomes.
    Koga K; Matsumoto K; Akiyoshi T; Kubo M; Yamanaka N; Tasaki A; Nakashima H; Nakamura M; Kuroki S; Tanaka M; Katano M
    Anticancer Res; 2005; 25(6A):3703-7. PubMed ID: 16302729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of exosomes for subsequent mRNA, MicroRNA, and protein profiling.
    Rani S; O'Brien K; Kelleher FC; Corcoran C; Germano S; Radomski MW; Crown J; O'Driscoll L
    Methods Mol Biol; 2011; 784():181-95. PubMed ID: 21898221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of exosome-like vesicles derived from breast cancer cells.
    Palazzolo G; Albanese NN; DI Cara G; Gygax D; Vittorelli ML; Pucci-Minafra I
    Anticancer Res; 2012 Mar; 32(3):847-60. PubMed ID: 22399603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of conditioned medium factors on productivity and cell physiology in Trichoplusia ni insect cell cultures.
    Calles K; Eriksson U; Häggström L
    Biotechnol Prog; 2006; 22(3):653-9. PubMed ID: 16739946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of Extracellular Vesicles Using a CELLine Adherent Bioreactor Flask.
    Artuyants A; Chang V; Reshef G; Blenkiron C; Chamley LW; Leung E; Hisey CL
    Methods Mol Biol; 2022; 2436():183-192. PubMed ID: 34490596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes.
    Keller S; König AK; Marmé F; Runz S; Wolterink S; Koensgen D; Mustea A; Sehouli J; Altevogt P
    Cancer Lett; 2009 Jun; 278(1):73-81. PubMed ID: 19188015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrimination between exosomes and HIV-1: purification of both vesicles from cell-free supernatants.
    Cantin R; Diou J; Bélanger D; Tremblay AM; Gilbert C
    J Immunol Methods; 2008 Sep; 338(1-2):21-30. PubMed ID: 18675270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.